osimertinib
astrazeneca
['adaura', 'osimertinib', 'aura ,(-laura)']
updated (+ 2 yr) results from adaura including cns data. median duration of exposure to osimertinib 35.8 m. the benefit is maintained. os still awaited. #esmo22 
MD, PhD, Prof of Respiratory Medicine, Thoracic Oncology Specialist @CHUdeToulouse, @IUCTOncopoleICR; Researcher, INSERM @crctoncopole #LCSM ????? ?? ??